Grants for County governments - Health

This funding opportunity supports U.S. colleges and universities in developing programs that enhance diversity and provide research training for undergraduate students from underrepresented groups, preparing them for advanced biomedical research careers.

USAID/DRCs vision for Kitumaini is a five-year long activity that will focus on service deliveryresults in five (5) health zones in Haut-Katanga, with possible expansion to other provinces asguided by Office of the Global AIDS Coordinator (OGAC)/PEPFAR. This activity also intends tostrengthen the capacity of local sub-recipients to enhance their capabilities to receive assistanceawards from USAID through transition award(s). This service delivery and capacity buildingactivity will include all aspects of HIV epidemic control. Activities will take place in health zonesassigned to USAID/DRC. This service delivery activity will prioritize services that focus on prioritypopulations, orphans and vulnerable children (OVC) and key populations (KP). The recipient willcoordinate with other implementing partners to facilitate the transition of the existing KPprogram, Meeting Targets and Maintaining Epidemic Control (EpiC) to Kitumaini.

HRSA-25-002, HRSA-25-003, and HRSA-25-004 announces the opportunity to apply for funding under Ryan White HIV/AIDS Program (RWHAP) Part C Early Intervention Services (EIS) Program: Existing Geographic Service Areas. The purpose of this program is to provide comprehensive primary health care and support services in an outpatient setting for low-income people with HIV. Under this announcement, successful applicants must provide: (1) counseling for individuals with respect to HIV; (2) targeted HIV testing; (3) periodic medical evaluations of individuals with HIV and clinical and diagnostic services for HIV care and treatment; (4) therapeutic measures for preventing and treating the deterioration of the immune system, and for preventing and treating conditions arising from HIV; and (5) referrals for people with HIV to appropriate providers of health care and support services. These services are to be provided directly or through referrals, contracts, or memoranda of understanding (MOUs). This competition is open to current RWHAP Part C EIS recipients and new organizations proposing to provide RWHAP Part C EIS funded services in the geographic service areas listed in Appendix C. Please note that there are 3 funding announcement numbers included in this document with 3 different periods of performance (See Appendix C). If you are applying for more than one service area, you must submit a separate application for each proposed service area. All allowable services must relate to HIV diagnosis, care, and support, and must adhere to established HIV clinical practice standards consistent with U.S. Department of Health and Human Services (HHS) Guidelines. Please refer to the HIV/AIDS Bureau (HAB) Policy Clarification Notice (PCN) 16-02 Ryan White HIV/AIDS Program Services for a list of RWHAP allowable core medical and support services and their descriptions. According to the RWHAP Part C statute: At least 50 percent of the amount received under the award must be expended on EIS costs (except counseling and referrals/linkage to care); At least 75 percent of the award (after reserving amounts for administrative costs, planning/evaluation, and clinical quality management (CQM)) must be expended on core medical services costs (Please note: EIS is a subset of this 75 percent of the award) and; Not more than 10 percent of the total RWHAP Part C award funds can be expended on administrative costs. Applicants seeking a waiver to the core medical services requirement must submit a waiver request with this application as Attachment 15. For more details, see Program Requirements and Expectations.

This funding opportunity supports innovative research on how environmental toxicants impact RNA modifications and their role in health issues, targeting universities, nonprofits, and for-profit organizations involved in related studies.

The Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) is a funding opportunity designed to support early-stage physicians and health professionals who are committed to aging and aging-related diseases research, helping them to enhance their research and leadership skills, establish independent research programs, and prepare to lead in their field to improve health outcomes for older individuals.

This funding opportunity provides financial support to organizations working in Botswana to strengthen laboratory and health systems for effective management of HIV and TB programs.

This grant provides funding for researchers and institutions to develop advanced tissue-engineered models that better mimic cancer biology, aiming to improve understanding and treatment of various cancer types.

This funding opportunity provides financial support for organizations to develop and evaluate innovative strategies aimed at preventing and addressing elder abuse and neglect among older adults and individuals with disabilities.

This funding opportunity is designed to support a centralized leadership and coordination center that will oversee a comprehensive study on the health of adults living with HIV and similar individuals, focusing on improving health outcomes and addressing disparities through community engagement and scientific research.

This funding opportunity is designed to support research sites that will enroll patients with Type 1 Diabetes at risk of kidney disease, enabling the study of kidney biopsies to advance understanding and treatment of diabetic nephropathy.

This funding opportunity provides financial support to various organizations focused on improving maternal and child health services across the United States, including state programs, urban initiatives, and home visiting services.

This funding opportunity provides financial support to accredited organizations in Puerto Rico to enhance poison control services and improve public health responses to poisoning incidents.

This grant provides funding for researchers to develop innovative methods for improving cancer communication and prevention strategies in today's digital landscape, focusing on the impact of online information and health disparities.

This grant provides funding to organizations that engage with justice-involved individuals to conduct research aimed at preventing substance use disorders and overdose, enhancing community support and treatment access.

This funding opportunity provides financial support for research organizations to establish expert panels that will evaluate and curate genomic variants linked to important diseases, enhancing clinical understanding and treatment options.

The Small Business and Not-For-Profit Support Grant Program, initiated by the City of Chicago and funded through the American Rescue Plan Act, aims to provide financial assistance to small businesses and nonprofits. This program is designed to help these entities recover from economic losses sustained due to the COVID-19 pandemic. The City of Chicago, through its Department of Business Affairs and Consumer Protection (BACP), is seeking a qualified organization to administer this $21.5 million grant program. The primary beneficiaries of this grant program are eligible small businesses and nonprofits located within Chicago. The impact goals are centered around stabilizing their operations, supporting their workforce, and mitigating the long-term economic effects of the pandemic. By providing these funds, the program intends to foster economic resilience within the local business and nonprofit ecosystem. The program's priorities and focus are clearly on economic recovery and stability for the most vulnerable sectors affected by the pandemic. The selection of an administering organization will be based on their understanding of the city contractor's needs, the local small business and nonprofit landscape, and the City of Chicago's processes, ensuring efficient and effective distribution of funds. Expected outcomes include a stabilized small business sector and a stronger nonprofit presence in Chicago, both equipped to navigate future economic challenges. Measurable results would likely involve tracking the number of businesses and nonprofits served, jobs retained or created, and the overall economic recovery indicators within the city. While the specific foundation's strategic priorities and theory of change are not explicitly detailed here, the underlying theory is that direct financial support to these entities will lead to broader economic stability and community well-being.

This funding opportunity provides support for research institutions to conduct early-phase clinical trials focused on cancer prevention interventions across various organ sites.

This funding opportunity provides financial support to organizations working in Malawi to implement comprehensive HIV prevention strategies, focusing on reducing new infections and improving health outcomes for targeted populations.

This NOFO aims to conduct diabetes surveillance across health system and/or health plan membership-based centers to: (1) Estimate incidence and prevalence of diabetes in youth (;lt; 18 years) and young adults (1844 years) in the United States. These estimates are sought by diabetes type, demographic traits, health insurance status, and geographic area to identify disparities in diabetes burden; and (2) Ascertain the prevalence of risk factors for diabetes complications, occurrence of acute and chronic diabetes complications, and use of diabetes medications among youth and young adults with diabetes. This NOFO has two (2) components to achieve the purpose of the program. Component A focuses on surveillance of diabetes among youth (;lt; 18 years) and young adults (1844 years). Component B serves as a Coordinating Center to provide an infrastructure for standardized approaches, analytical methods, and measures to be used for surveillance across sites. It will also develop validation protocols, serve as a data repository, and provide statistical expertise.

This funding opportunity supports innovative research into how inflammasome activation affects individuals with HIV and substance use disorders, aiming to uncover mechanisms and potential therapeutic targets to improve health outcomes.